Syndax Pharmaceuticals, Inc. (SNDX)
20.52
-0.13
(-0.63%)
USD |
NASDAQ |
May 07, 10:59
Syndax Pharmaceuticals SG&A Expense (TTM) : 176.24M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cogent Biosciences, Inc. | 51.68M |
| Vera Therapeutics, Inc. | 100.22M |
| Biogen, Inc. | 2.468B |
| Stryker Corp. | 8.632B |
| Corcept Therapeutics, Inc. | 503.42M |